Artificial intelligence is rapidly reshaping the healthcare sector, with medical imaging at the forefront of this transformation. According to recent research, the global market for AI-powered diagnostics—currently valued at $1.9 billion—is expected to skyrocket to $46.6 billion by 2034, expanding at a compound annual growth rate of 33.7%.
AI-driven software platforms, cloud integration systems, and diagnostic tools now account for 60% of total imaging revenues, growing annually at 43%. This makes it the fastest-growing segment within health AI. Beyond diagnostics, AI-powered clinical decision support tools and patient management systems are also expanding, allowing agile startups to compete with industry giants.
Machine learning remains the most adopted AI technology in healthcare, used by 48% of institutions. Other fast-growing areas include computer vision, natural language processing (NLP), 3D/4D imaging, and cloud-based tools.
Siemens Healthineers has emerged as a major player, partnering with Google Cloud to boost AI and cloud services. It also acquired Advanced Accelerator Applications (AAA) and Dotmatics, further strengthening its AI and software portfolio. Meanwhile, other global firms like GE, Philips, and France's Dassault Systèmes are heavily investing in life sciences and healthtech.
Siemens Healthineers is collaborating with more than 100 startups. "Innovation is born not in isolation but through collaboration," said Amira Romani, senior vice president of innovation and strategy ecosystems. "The real goal is improving patient outcomes."
Romani described AI as “the glue” connecting healthcare technologies, enabling early diagnosis, personalized treatment, and workflow integration. “Doing AI just for the sake of AI is meaningless,” she said, emphasizing the importance of scalable, patient-focused solutions.
Türkiye is also emerging as a key hub for AI innovation. Siemens Healthineers recently opened an innovation center in Istanbul, drawn by the region’s energy and talent. Romani stated their goal is to scale Turkish-developed healthcare solutions for global markets.
The number of AI startups in Türkiye has grown 17-fold since 2017, reaching 411 as of Q2 2025, according to the Türkiye Artificial Intelligence Initiative (TRAI). Generative AI dominates the space, with six of the 20 newly added startups focused on content creation, large language models, and AI assistants.
“The growth is both quantitative and qualitative,” said TRAI General Manager Can Sinemli. “Generative AI is pushing our ecosystem closer to global competitiveness.”
Türk Telekom’s venture arm, TT Ventures, has invested in startups like Virasoft, Albert Health, and Aivisiontech, targeting early diagnosis and chronic disease management. Other promising firms include Segmentify (e-commerce AI), Mindsite (real-time marketing insights), and Mistikist (AI for mental health).
Meanwhile, Türkiye’s 212 NexT fund recently joined a €15 million Series A round for French sustainable dyeing tech startup EverDye. The fund aims to back scalable deep-tech ventures that tackle industrial sustainability.
EverDye’s solution reduces textile dyeing emissions significantly and has already completed a successful pilot collection with U.S. brand Adore Me, owned by Victoria’s Secret.
In a recent industry event, executives from PwC, Nvidia, Red Hat, and OdineLabs, as well as academics from Georgia Tech and Istanbul Technical University, discussed AI’s strategic role in enterprise transformation.
“AI is no longer just a technical tool—it’s a strategic driver of competitiveness,” said Odine Chair Alper Tunga Burak. Presentations covered next-generation AI solutions across decision-making, networks, data, and security.
As AI continues to mature, the convergence of startup agility, corporate investment, and public-private partnerships is propelling healthcare toward a smarter, more connected future—centered not on technology alone, but on meaningful patient outcomes.
Source: Daily Sabah
Bd-pratidin English/ Jisan
